Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Menlo Park, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oruka Therapeutics, Inc. has filed 1,498 SEC EDGAR filings since 12 Jun 1997

SEC filing history

Showing 676-700 of 936 matching filings.

Per page
25
Current page
28
CT ORDER File 000-22873

CT ORDER filing

Filing date
27 Jun 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-187508

424B4

Filing date
09 Jun 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

FORM 8-K

Filing date
09 Jun 2014
Reporting date
05 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-187508

424B4

Filing date
14 May 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-195054

EFFECT filing

Filing date
06 May 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
02 May 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-22873

CT ORDER filing

Filing date
18 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-22873

DEFA14A

Filing date
15 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-22873

DEF 14A

Filing date
15 Apr 2014
Reporting date
05 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
14 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-195054

FORM S-3

Filing date
04 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-187508

424(B)(4)

Filing date
21 Mar 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-187508

424B4

Filing date
03 Mar 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
03 Mar 2014
Reporting date
27 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Mar 2014
Reporting date
27 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Mar 2014
Reporting date
27 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Mar 2014
Reporting date
27 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-212270

D filing

Filing date
20 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-187508

424B4

Filing date
18 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-22873

8-K

Filing date
18 Feb 2014
Reporting date
11 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Feb 2014
Reporting date
11 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Feb 2014
Reporting date
11 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .